BioSpace News Archive

The collaborative study of regulatory-grade real world evidence in cardiovascular medicine demonstrates data and technologies to support high credibility clinical assertions

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research

MediSpend welcomes Diana Borges as vice president of compliance solutions and Françoise Renaud as vice president of client operations.

Innovative Collaboration with Lyft, Blue Cross Blue Shield Institute and Hill Physicians helps solve common hurdle in accessing care - transportation

AACR Cancer Progress Report 2019 details 27 new cancer treatments, a record high number of U.S. cancer survivors, and the benefit of increasing federal investments in medical research through the National Institutes of Health and the National Cancer Institute

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to Gazyva® for adults with lupus nephritis.

Biovica and the SWOG Cancer Research Network have entered into an agreement to study the clinical benefit of DiviTum® using patient blood samples from SWOG 0226, a clinical trial that showed that women with metastatic hormone receptor-positive breast cancer live longer when they receive a combination of two anti-estrogen drugs.

Doximity the professional medical network, released new research on the growing shortage of obstetricians and gynecologists and the potential crisis this poses for women’s healthcare.

Freudenberg Medical, a global developer and manufacturer of finished medical devices, composite catheter shafts, components, and minimally invasive solutions for the medical device industry, announced several new options for medical device companies looking to accelerate time to market.

Boston Scientific Corporation announced key data that will be presented at the 31st Transcatheter Cardiovascular Therapeutics, the annual scientific symposium of the Cardiovascular Research Foundation, in San Francisco, on September 25 - September 29.